Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 10
EC Number Crystallization (Commentary)
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43crystal structure of Sirt5 in complex with a thioacetyl peptide is obtained, The corresponding acetyl peptide could not be crystallized with Sirt5
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43crystal structure of Sirt5 in complex with fluor-de-Lys peptide and resveratrol and crystal structure of Sirt5 in complex with fluor-de-Lys peptide and piceatannol
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43crystal structures of a binary complex of SIRT5 with an H3K9 succinyl peptide and a binary complex of SIRT5 with a bicyclic intermediate obtained by incubating SIRT5-H3K9 thiosuccinyl peptide co-crystals with NAD+
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43crystals of native and selenomethionine-derivatized cobB are grown at room temperature using the hanging-drop, vapor-diffusion method. The crystal structure of the Escherichia coli cobB core domain (residues 40–274) in complex with an 11-residue peptide containing residues 12–19 of histone H4 and acetylated at lysine 16 is determined by a combination of Zn2+ and Se multiwavelength anomalous diffraction to 1.96 A resolution
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43hanging drop vapor diffusion method at 18°C. X-ray crystal structures of the ternary complex of SIRT5 bound to a peptide substrate and carba-NAD+ (an unreactive NAD+ analogue)
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43hanging drop vapor diffusion method at 4°C, crystal structure of wild-type enzyme, mutant enzyme S24A, mutant enzyme H80N, mutant enzyme F159A, and triple Sir2 mutant (D102G/F159A/R170A)
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43hanging drop vapor-diffusion method at 20°C. Crystal structures of SIRT5 in complex with ADP-ribose, and crystal structures of SIRT5 bound to suramin
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43purified recombinant detagged enzyme in complex with peptide inhibitors 2 and 15, sitting drop vapor diffusion method, mixing of 10 mg/ml protein with 1 mM inhibitor, crystallization in 0.002 ml of reservoir solution containing 0.1 M HEPES, pH 7.5, and 20% PEG 3350, 20°C, 2-4 days, X-ray diffraction structure determination and analysis at 2.4 A resolution, molecular replacement with search model PDB 4UTV and modeling
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43purified recombinant enzyme SIRT5 in complex with succinylated histones, crystals of Sirt5-H4K122su and Sirt5-H2AK95su complexes are obtained from 0.1 M sodium cacodylate, pH 5.5, and 25% w/v PEG 4000 at 22°C. Sirt5-H4K91su complex is crystallized from 0.1 M Bis-Tris, pH 5.5, and 25% w/v PEG 3350, and Sirt5-H2BK120su complex is grown in 0.2 M sodium acetate trihydrate, 0.1 M sodium cacodylate trihydrate, pH 6.5, and 30% w/v PEG 8000, X-ray diffraction structure determination and analysis at 1.70-2.30 A resolution, molecular replacement using the structures PDB ID 3RIY as a searching model
Display the word mapDisplay the reaction diagram Show all sequences 2.3.1.B43vapor diffusion at 20°C, crystal structure of the enzyme bound to KGLGKGGA(N6-succinyl)KRHRKW
Results 1 - 10 of 10